1 result for month: 10/2018


Medicines – In Support of Follow-On Innovation

25 Sep 2018 In a recent article Professor Christopher Holman (University of Missouri - Kansas City School of Law) again comes out in support of patent protection for the embodiment of follow-on innovation in medicines (Christopher M. Holman, “Inside views: Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection”, Intellectual Property Watch, 21 September 2018). Follow-on pharmaceutical innovation seeks to improve upon existing medicines by a range of alternatives such as offering a safer and more effective variation than the original product or creating a more patient- and treatment-friendly formulation. Despite its ...